CNMD - CONMED - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

CNMD is currently covered by 6 analysts with an average price target of $61.14. This is a potential upside of $9.99 (19.53%) from yesterday's end of day stock price of $51.15.

CONMED's activity chart (see below) currently has 143 price targets and 117 ratings on display. The stock rating distribution of CNMD is 78.13% BUY and 21.88% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 65.21% with an average time for these price targets to be met of 149.75 days.

Highest price target for CNMD is $70, Lowest price target is $55, average price target is $68.17.

Most recent stock forecast was given by MATT O'BRIEN from PIPER SANDLER on 31-Jul-2025. First documented stock forecast 16-Jan-2015.

Currently out of the existing stock ratings of CNMD, 25 are a BUY (78.13%), 7 are a HOLD (21.88%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$68

$16.85 (32.94%)

$80

2 days ago
(31-Jul-2025)

15/22 (68.18%)

$16.85 (32.94%)

221

Buy

$61

$9.85 (19.26%)

$61

1 months 21 days ago
(12-Jun-2025)

21/38 (55.26%)

$6.03 (10.97%)

236

Hold

$57

$5.85 (11.44%)

$70

3 months 1 days ago
(01-May-2025)

3/4 (75%)

$-0.19 (-0.33%)

22

Buy

$55

$3.85 (7.53%)

$75

3 months 5 days ago
(28-Apr-2025)

13/18 (72.22%)

$4.16 (8.18%)

144

Hold

$70

$18.85 (36.85%)

$75

5 months 27 days ago
(06-Feb-2025)

3/7 (42.86%)

$2.64 (3.92%)

190

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is CNMD (CONMED) average time for price targets to be met?

On average it took 149.75 days on average for the stock forecasts to be realized with a an average price target met ratio 65.21

Which analyst has the current highest performing score on CNMD (CONMED) with a proven track record?

MATT O'BRIEN

Which analyst has the most public recommendations on CNMD (CONMED)?

Matt O'brien works at PIPER SANDLER and has 5 price targets and 7 ratings on CNMD

Which analyst is the currently most bullish on CNMD (CONMED)?

Matthew Mishan with highest potential upside - $89.85

Which analyst is the currently most reserved on CNMD (CONMED)?

Matthew Taylor with lowest potential downside - -$15.85

CONMED in the News

CONMED Second Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags

CONMED (NYSE:CNMD) Second Quarter 2025 Results Key Financial Results Revenue: US$342.3m (up 3.1% from 2Q 2024). Net income: US$21.4m (down 28% from 2Q 2024). Profit margin: 6.3% (down from 9.0% in 2Q 2024). EPS: US$0.69 (down from US$0.97 in 2Q 2024). This technology could replace computers: discover the 20 stocks are working to make quantum...

Conmed projects $20M annual supply chain savings as growth drivers accelerate

Earnings Call Insights: CONMED Corporation (CNMD) Q2 2025 MANAGEMENT VIEW * Patrick J. Beyer, President and CEO, highlighted “total sales for the quarter were $342.3 million, which came in slightly above the high end of our guidance range on year-over-year growth of 3.1% as reported and 2.9% in constant currency.” Beyer emphasized that growth was...
Show more

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?